DEIGNAN CHARLES A. (Chief Financial Officer) sold 3.2% of their position (12.90K shares) of CLEARSIDE BIOMEDICAL, INC. on the open market
Open‑market sale worth $16.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/19/2024ACC: 0001209191-24-001959
Officer· Chief Financial Officer
Since Feb 2019
+187.10K
Net shares
Net buyer
$16.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
200K acquired · 12.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.90K
Price / share
$1.28
Trade value
$16.51K
% of position
3.2%
1/19/2024
397.56K→384.66K
Total
Net shares
−12.90K
Net value
-$16.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2024 | S · Sale | −12.90K | $1.28 | $16.51K | 3.2% | 397.56K | 384.66K |
| Total | −12.90K | -$16.51K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
200K shares
Shares
+200K
Strike price
1.29
Held after
200K
Exercisable
—
1/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock200K shares | 1/18/2024 | A · Award | +200K | 1.29 | — | 200K |